Selected mechanisms inducing resistance to immunotherapy in patients with ovarian cancer
Recently, the intensive development of immunotherapies in the treatment of malignant tumors has been observed. The investigated treatment approaches including specific monoclonal antibodies, adoptive therapy and also anticancer vaccinations. The implementation of immunotherapy seems to be promising in treatment of the most malignant and fatal tumors including ovarian cancer. However, current findings have shown only a nonsignificant improvement of patients' survival. The possible cause of failure may be immunotherapy barriers that are a result of low immunogenicity level of ovarian cancer cells, mutation variability, and also the presence of a specific, immunosuppressive tumor microenvironment, which stimulates the cancer progression. The review presents the selected mechanisms of tumor resistance to immunological therapy. In order to project effective treatment approaches, it is necessary to understand both, mechanisms leading to the correct response for the treatment and causing therapeutic failures, resulting from resistance to therapy.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Wiadomosci lekarskie (Warsaw, Poland : 1960) - 72(2019), 7 vom: 09., Seite 1397-1402 |
| Sprache: |
Polnisch |
|---|
| Beteiligte Personen: |
Pietrzyk, Natalia [VerfasserIn] |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 29.08.2019 Date Revised 29.08.2019 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM300087721 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300087721 | ||
| 003 | DE-627 | ||
| 005 | 20231225101747.0 | ||
| 007 | tu | ||
| 008 | 231225s2019 xx ||||| 00| ||pol c | ||
| 028 | 5 | 2 | |a pubmed24n1000.xml |
| 035 | |a (DE-627)NLM300087721 | ||
| 035 | |a (NLM)31398175 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a pol | ||
| 100 | 1 | |a Pietrzyk, Natalia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Selected mechanisms inducing resistance to immunotherapy in patients with ovarian cancer |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 29.08.2019 | ||
| 500 | |a Date Revised 29.08.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Recently, the intensive development of immunotherapies in the treatment of malignant tumors has been observed. The investigated treatment approaches including specific monoclonal antibodies, adoptive therapy and also anticancer vaccinations. The implementation of immunotherapy seems to be promising in treatment of the most malignant and fatal tumors including ovarian cancer. However, current findings have shown only a nonsignificant improvement of patients' survival. The possible cause of failure may be immunotherapy barriers that are a result of low immunogenicity level of ovarian cancer cells, mutation variability, and also the presence of a specific, immunosuppressive tumor microenvironment, which stimulates the cancer progression. The review presents the selected mechanisms of tumor resistance to immunological therapy. In order to project effective treatment approaches, it is necessary to understand both, mechanisms leading to the correct response for the treatment and causing therapeutic failures, resulting from resistance to therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a ovarian cancer | |
| 650 | 4 | |a resistance mechanisms | |
| 650 | 4 | |a tumor microenvironment | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 700 | 1 | |a Piętak, Patrycja |e verfasserin |4 aut | |
| 700 | 1 | |a Pawłowska, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Suszczyk, Dorota |e verfasserin |4 aut | |
| 700 | 1 | |a Chudzik, Agata |e verfasserin |4 aut | |
| 700 | 1 | |a Kotarski, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Wertel, Iwona |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiadomosci lekarskie (Warsaw, Poland : 1960) |d 1960 |g 72(2019), 7 vom: 09., Seite 1397-1402 |w (DE-627)NLM00001138X |x 0043-5147 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2019 |g number:7 |g day:09 |g pages:1397-1402 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2019 |e 7 |b 09 |h 1397-1402 | ||